As the highly anticipated tamil films
Jana Nayagan and
Parasakthi gear up for release, theatre owners have voiced concerns over the
proposed revenue-sharing model, which reportedly requires them to give
75–80% of ticket revenue to the distributors. This has created unease among exhibitors, especially with both films releasing around the same time.
What Theatre Owners Are SayingExhibitors argue that such a
high revenue share for distributors leaves them with limited profits, making it challenging to manage operational costs, staff salaries, and maintenance. Many feel that while blockbuster films attract large audiences, the
high percentage taken by distributors reduces the incentive for theatres to promote or screen multiple shows.
Impact of the ClashThe simultaneous release of
Jana Nayagan and
Parasakthi adds to the pressure. Theatre owners are concerned that:
Audience footfall will be divided, reducing per-show revenue.Smaller theatres might struggle to afford the revenue share, leading to
limited screenings.Some multiplexes may
prioritize only one film to minimize financial risk, affecting audience access.
Industry ContextRevenue-sharing disputes are not new in the tamil film industry. Typically,
distributors demand higher percentages for films with big stars or high expectations. However, a 75–80% share is considered unusually steep by many theatre owners, especially when
two major films are releasing simultaneously.
Looking AheadTheatres and distributors are expected to negotiate in the coming days to
find a workable solution that ensures both films get sufficient screens while protecting exhibitor profits. Fans are keeping a close watch, as this clash could affect
ticket availability and show timings during the opening weekend.
ConclusionThe
Jana Nayagan vs
Parasakthi release clash highlights the ongoing
tension between distributors and theatre owners in tamil cinema. While fans eagerly await both films, the outcome of these negotiations will play a key role in determining
how widely and successfully the films are screened.
Disclaimer:The views and opinions expressed in this article are those of the author and do not necessarily reflect the official policy or position of any agency, organization, employer, or company. All information provided is for general informational purposes only. While every effort has been made to ensure accuracy, we make no representations or warranties of any kind, express or implied, about the completeness, reliability, or suitability of the information contained herein. Readers are advised to verify facts and seek professional advice where necessary. Any reliance placed on such information is strictly at the reader’s own risk.